New study published in Lancet Infectious Diseases suggests that Bharat Biotech COVID19 vaccine, COVAXIN induces higher neutralising antibody response in children aged 2-18 years. The company had conducted an age de-escalation study to assess the safety, reactogenicity, and immunogenicity of an inactivated COVID-19 vaccine, COVAXIN.
- Read more about COVAXIN induces higher neutralising antibody response in children, says study
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/covaxin-induces-higher-neutralising-antibody-response-in-children-says-study
No comments:
Post a Comment